Donovan Leung

Donovan Leung is an Investment Manager in Life Sciences Venture Capital at Rosetta Capital, based in the Greater London area of England, United Kingdom.1 His professional background includes:

Experience

• Current Role: Life Sciences Venture Capital - Investment Manager at Rosetta Capital since March 20221
• Previous Positions:
  • Healthcare Investment Banking Associate at The Fulford Group Ltd (May 2020 - April 2022)
  • Strategy Consultant in the Financial Institutions Team at IQVIA (July 2017 - May 2020)
  • Analyst at Apex Healthcare Consulting (September 2015 - April 2017)

Education

• Bachelor's Degree in Biochemistry and Tropical Disease Biology from the University of Liverpool (2011-2014)1
  • Joint degree with the Liverpool School of Tropical Medicine
  • Awarded full academic scholarship

Skills and Expertise

Donovan has experience in various aspects of healthcare and life sciences, including:

• Investments in early-stage life science companies
• M&A and corporate finance advisory
• Commercial due diligence
• Portfolio optimization and growth strategy
• Pricing and market access

His deal size experience ranges from $300 million to over $50 billion.1

Languages

• English: Native or bilingual proficiency
• Cantonese: Limited working proficiency1

Donovan Leung's diverse background in healthcare investment banking, strategy consulting, and scientific research has positioned him as a valuable professional in the life sciences venture capital sector.